NCT04754165

Brief Summary

The objective of this study is to investigate whether the addition of immersive virtual reality (VR) in the immediate postoperative period to an enhanced recovery after surgery (ERAS) protocol could improve postoperative recovery from bariatric surgery.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Mar 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Mar 2022Jun 2026

First Submitted

Initial submission to the registry

January 29, 2021

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 15, 2021

Completed
1.1 years until next milestone

Study Start

First participant enrolled

March 21, 2022

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

July 14, 2025

Status Verified

July 1, 2025

Enrollment Period

3.2 years

First QC Date

January 29, 2021

Last Update Submit

July 10, 2025

Conditions

Keywords

Virtual RealityERAS

Outcome Measures

Primary Outcomes (1)

  • Quality of Recovery Questionnaires (QoR-15)

    The primary outcome of this study will be patient reported quality of recovery at time of PACU discharge, as assessed by the QOR-15. The QOR-15 is a validated instrument to assess postoperative recovery from the patient's perspective, assessing overall well-being, nausea, pain, and anxiety and depression following surgery.

    Measured at time of post anesthesia care unit discharge, on average of 1 to 5 hours after surgery.

Secondary Outcomes (7)

  • PACU Opioid Requirements

    Measured throughout a patient's stay in the post anesthesia care unit, on average 1 to 5 hours after surgery.

  • Length of PACU stay

    Duration of the patient's stay in the post anesthesia care unit, from time of admission to time of readiness for PACU discharge, on average 1 to 5 hours.

  • PACU pain scores using numeric rating scale

    Administered every hour following admission to the post anesthesia care unit until discharge from the post anesthesia care unit, on average 1 to 5 hours.

  • Postoperative Quality of Recovery Questionnaires (QoR-15) score

    Measured at 24 hours after post anesthesia unit discharge.

  • Hospital length of stay

    Measured throughout the patients stay at the hospital, on average 1 to 3 days.

  • +2 more secondary outcomes

Study Arms (2)

Immersive Virtual Reality plus the enhanced recovery after surgery protocol

EXPERIMENTAL

Patients in the immersive VR group will don a VR headset connected to a software platform on a tablet, as well as noise cancelling headphones in the post anesthesia care unit (PACU) after surgery. Patients can choose their desired experience within the VR software from a selection of immersive environments and/or video content. Examples include sitting in a canoe on a river, on a peaceful meadow or in a forest. Patients also have the option to listen to guided meditation or select from a library of videos to watch on a web-based user interface. Patients in the VR group will also be treated according to the existing enhanced recovery after surgery protocol.

Other: Virtual Reality Immersive Relaxation

Enhanced recovery after surgery protocol

NO INTERVENTION

Subjects in the control group will only undergo standard enhanced recovery after surgery care.

Interventions

The VR software developed allows patients to select from scenery such as mountains, the beach or from a selection of short videos, which are intended to promote relaxation.

Immersive Virtual Reality plus the enhanced recovery after surgery protocol

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Patients undergoing laparoscopic bariatric surgery at BIDMC under general anesthesia.

You may not qualify if:

  • Age\<18
  • Open wounds or active infection of the face or eye area
  • History of seizures or other symptom linked to an epileptic condition
  • Patients with hearing aids who are unable to tolerate wearing headphones with their hearing aids
  • Patients with a pacemaker or other implanted medical device
  • Droplet or airborne precautions (as determined by BIDMC infection control policy)
  • Non English Speaking or non Spanish Speaking
  • Chronic opioid dependence (existing oral opioid prescription for \>3 months, methadone, suboxone)
  • Drop Out Criteria: (after enrollment and randomization, before intervention)
  • \- Surgery is converted to an open procedure (laparotomy), the patient will be withdrawn from the study as these patients are treated in a manner that is different than standard ERAS protocols

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States

Location

Related Publications (1)

  • Espinosa-Leon JP, Mathura R, Chen G, Joseph M, Sadhwani T, Beydoun N, Hernandez ER, Riley T, Goodspeed V, O'Gara BP. Postoperative virtual reality for recovery after bariatric surgery: study protocol for a randomised clinical trial. BJA Open. 2024 Feb 5;9:100258. doi: 10.1016/j.bjao.2024.100258. eCollection 2024 Mar.

MeSH Terms

Conditions

Pain, PostoperativePostoperative Complications

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Brian P O'Gara, MD,MP

    Beth Israel Deaconess Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Assessors of the QOR15 recovery scale will be blinded to group assignment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Research participants will be randomized to one of two groups: immersive VR plus ERAS, or ERAS alone in a 1:1 allocation. The first 6 patients enrolled will be assigned to the VR group for the purposes of a pilot phase with the objective of identifying and refining any issues with the intervention. Data for these patients will not be included in the statistical analysis.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Anaesthesia

Study Record Dates

First Submitted

January 29, 2021

First Posted

February 15, 2021

Study Start

March 21, 2022

Primary Completion

June 1, 2025

Study Completion (Estimated)

June 30, 2026

Last Updated

July 14, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations